Where does Peter Barrett work?

Peter Barrett is Partner at Atlas Venture and Board director at Synlogic.

What does Peter Barrett invest in?

Peter Barrett invests in Biotech.

What check size does Peter Barrett write?

Peter Barrett typically writes checks of $500K – $5M.

Where did Peter Barrett go to school?

Peter Barrett studied at Northeastern University (Phd, Analytical Chemistry).

Peter Barrett

Investor

Partner at Atlas Venture · Board director at Synlogic

Massachusetts

Writes $500K – $5M checks · typically $2M

About

Peter Barrett has worked at Atlas Venture since 2002, helping create therapeutic and drug discovery platform companies. Before Atlas, he co-founded Celera Genomics, serving as executive vice president and chief business officer, and previously held senior management roles at Applera. He holds a BS in chemistry from Lowell Technological Institute (now UMass Lowell) and a PhD in analytical chemistry from Northeastern University.

Contact· self-published, not guessed

p•••@atlasventure.comreveal

Invests in

Biotech

Board director at Synlogic

Intro paths

→

In turn, Peter can intro founders to Synlogic's investors below.

Synlogic's investors · 7

Atlas VentureCambridge · $500K – $1M checks New Enterprise Associates (NEA)Menlo Park · $200K – $40M checks · since 2016 NSG VenturesSingapore OrbiMedNew York · $1M – $75M checks · since 2017 Pfizer Venture Investments$5M – $20M checks Sofinnova VenturesMenlo Park · $100K – $15M checks Solasta VenturesBoston

Experience

Atlas VenturePartner
Harvard Business SchoolHarvard Business School Facultycurrent2016 — presentCambridge, Massachusetts, United States
ArchemixBoard Member2002 — 2010
Celera GenomicsExecutive Vice President1998 — 2002
PerkinElmerCorporate Vice Preisdent1979 — 1998

Deals · 1

Antegrin TherapeuticsBoard seat

via Atlas Venture · filed Aug 2017 · $26M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Board seats

AlnylamArchemixCadent TherapeuticsHarbour AntibodiesLarimar TherapeuticsMomentaNovamedNucleate BioObsidian TherapeuticsRevvitySirion TherapeuticsStromedixSynlogicVitae Pharmaceuticals

Sources: the firm's website · SEC Form D filings.

Colleagues at Atlas Venture

Aimee Raleigh

Principal at Atlas Venture

Bruce Booth

Partner at Atlas Venture

Chelsea Johnson

Principal at Atlas Venture

David Grayzel

Partner at Atlas Venture

Jason Rhodes

Partner at Atlas Venture

Jean-François Formela

Partner at Atlas Venture

Jernej Godec

Principal at Atlas Venture

Jodie Morrison

Venture Partner at Atlas Venture

Frequently asked questions

Who is Peter Barrett?: Peter Barrett has worked at Atlas Venture since 2002, helping create therapeutic and drug discovery platform companies. Before Atlas, he co-founded Celera Genomics, serving as executive vice president and chief business officer, and previously held senior management roles at Applera. He holds a BS in chemistry from Lowell Technological Institute (now UMass Lowell) and a PhD in analytical chemistry from Northeastern University.
Where does Peter Barrett work?: Peter Barrett is Partner at Atlas Venture and Board director at Synlogic.
What does Peter Barrett invest in?: Peter Barrett invests in Biotech.
What check size does Peter Barrett write?: Peter Barrett typically writes checks of $500K – $5M.
What boards does Peter Barrett sit on?: Peter Barrett holds tracked board seats at Alnylam, Antegrin Therapeutics, Archemix, Cadent Therapeutics, Harbour Antibodies, Larimar Therapeutics, Momenta, Novamed, Nucleate Bio, Obsidian Therapeutics.
Where did Peter Barrett go to school?: Peter Barrett studied at Northeastern University (Phd, Analytical Chemistry).